Takeda Pharmaceutical Company Limited (TAK) reported first half net profit to owners of company of 112.4 billion yen, down 40.0% from prior year. Earnings per share was 70.45 yen compared to 117.11 yen. Core operating profit was 639.2 billion yen, down 11.2%. Core EPS was 279 yen compared to 310 yen. For the six-month period ended September 30, 2025, revenue was 2.22 trillion yen, down 6.9% from previous year.
For fiscal year ending March 31, 2026, the company expects: basic earnings per share of 97.14 yen, and revenue of 4.5 trillion yen.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.